Published in Cell Immunol on August 01, 1980
Metabolism and possible health effects of aluminum. Environ Health Perspect (1986) 1.64
Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection. Immunology (1982) 0.90
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst (1984) 2.08
Clinical characteristics of responders to interferon therapy for relapsing MS. Neurology (2003) 1.73
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. J Immunol (1981) 1.58
Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst (1980) 1.49
Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli. J Natl Cancer Inst (1995) 1.47
Helper-dependent vector transmission of plant viruses. Annu Rev Phytopathol (1996) 1.47
Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans (1997) 1.45
Parent comprehension of polio vaccine information pamphlets. Pediatrics (1996) 1.44
An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis (1988) 1.43
Delayed recognition of podophyllum toxicity in a patient receiving epidural morphine. Anesth Analg (1990) 1.40
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm (1997) 1.40
Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys (2000) 1.32
Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer (1980) 1.31
Successful overweight prevention in adolescents by increasing physical activity: a 4-year randomized controlled intervention. Int J Obes (Lond) (2008) 1.29
Influence of dietary fat on postprandial glucose metabolism (exogenous and endogenous) using intrinsically (13)C-enriched durum wheat. Br J Nutr (2001) 1.29
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet (2009) 1.28
Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists. J Immunol (1984) 1.25
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J Immunol (2000) 1.23
Validity of combining heart rate and uniaxial acceleration to measure free-living physical activity energy expenditure in young men. J Appl Physiol (1985) (2012) 1.20
Miltefosine affects lipid metabolism in Leishmania donovani promastigotes. Antimicrob Agents Chemother (2007) 1.18
Aphid transmission of cauliflower mosaic virus requires the viral PIII protein. EMBO J (1999) 1.15
Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev (1982) 1.15
The grey mouse lemur: a non-human primate model for ageing studies. Ageing Res Rev (2011) 1.13
Splicing of cauliflower mosaic virus 35S RNA is essential for viral infectivity. EMBO J (1995) 1.12
Mechanisms of depressed reactivity to dinitrochlorobenzene and ultraviolet-induced tumors during ultraviolet carcinogenesis in BALB/c mice. Cell Immunol (1978) 1.09
Role of natural killer cells in host defense against cancer metastasis. Symp Fundam Cancer Res (1983) 1.08
HLA-DRw4 in pemphigus vulgaris patients in Israel. Tissue Antigens (1980) 1.08
Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice. Cancer Res (1981) 1.06
Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment. J Immunol (1983) 1.06
c-myc oncogene expression inhibits the initiation of myogenic differentiation. Exp Cell Res (1987) 1.05
Sexual transmission of human papillomaviruses in heterosexual and male homosexual couples, studied by DNA hybridisation. Genitourin Med (1988) 1.05
"Primatization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. Biotechnology (N Y) (1992) 1.04
Identification and characterization of a human T cell line-derived lymphokine with MAF-like activity distinct from interferon-gamma. J Immunol (1986) 1.04
Interaction between the open reading frame III product and the coat protein is required for transmission of cauliflower mosaic virus by aphids. J Virol (2001) 1.04
Effects of prostaglandins and cAMP levels on monocyte IL-1 production. Agents Actions (1989) 1.03
Evidence for phosphorylation and ubiquitinylation of the turnip yellow mosaic virus RNA-dependent RNA polymerase domain expressed in a baculovirus-insect cell system. Biochem J (2000) 1.03
Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma. Cancer Treat Res (2007) 1.03
Macrophage activation in rat models of inflammation and arthritis. Systemic activation precedes arthritis induction and progression. Arthritis Rheum (1986) 1.02
The role of natural killer cells in the control of tumor growth and metastasis. Biochim Biophys Acta (1985) 1.02
The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer. Ann Oncol (2007) 1.02
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Antimicrob Agents Chemother (1997) 1.01
CD3-associated heterodimeric polypeptides on suppressor hybridomas define biologically active inhibitory cells. Proc Natl Acad Sci U S A (1988) 1.00
SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid. Biochem Pharmacol (1987) 0.99
Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer. Dis Esophagus (2006) 0.99
Inhibition of T- and B-lymphocyte functions by normal immunosuppressive protein. Immunology (1975) 0.98
Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells. Immunology (1978) 0.98
Biochemical characterization of the helper component of Cauliflower mosaic virus. J Virol (2001) 0.98
The new Ghent criteria for Marfan syndrome: what do they change? Clin Genet (2011) 0.98
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States. Ann Surg Oncol (2013) 0.97
Simplified test for detecting the resistance of herpes simplex virus to acyclovir. J Med Virol (1990) 0.97
Judgments of trained observers on adverse drug reactions. Clin Pharmacol Ther (1979) 0.96
Structural requirements for in vivo and in vitro immunogenicity in hapten-specific delayed hypersensitivity. Cell Immunol (1973) 0.96
Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. Fertil Steril (1983) 0.96
Antibodies to species homologous tissue antigens in the rat. II. Circulating antibodies during the development of autoimmune renal disease. Clin Exp Immunol (1967) 0.96
Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma. Int J Oncol (1999) 0.95
Macrophage activation in rat models of inflammation and arthritis: determination of markers of stages of activation. Cell Immunol (1986) 0.95
Normal immunosuppressive protein inhibition of human and murine lymphoblastoid cell line proliferation. Eur J Immunol (1979) 0.95
Modification of the Fc region of a primatized IgG antibody to human CD4 retains its ability to modulate CD4 receptors but does not deplete CD4(+) T cells in chimpanzees. Clin Immunol (2001) 0.94
Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant. Vaccine (1992) 0.94
Effect of anti-epidermis antibodies on autografts and allografts in rats. Nature (1968) 0.94
Normal immunosuppressive protein purification and quantitative estimation experiments. J Immunol Methods (1979) 0.93
Interaction between the aphid transmission factor and virus particles is a part of the molecular mechanism of cauliflower mosaic virus aphid transmission. Proc Natl Acad Sci U S A (1994) 0.93
A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation. J Immunol (1998) 0.93
Cooperative effects in antibody formation produced by hapten-specific delayed sensitivity. J Immunol (1973) 0.92
Antibodies to species homologous tissue antigens in the rat. I. Naturally occurring circulating antibodies. Clin Exp Immunol (1967) 0.91
Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arthritis Rheum (1988) 0.91
Systematic molecular and cytogenetic screening of 100 patients with marfanoid syndromes and intellectual disability. Clin Genet (2013) 0.90
Pattern and cost of weight gain in previously obese women. Am J Physiol Endocrinol Metab (2002) 0.90
Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo. Proc Natl Acad Sci U S A (1992) 0.90
Right-hemispheric dominance for visual remapping in humans. Philos Trans R Soc Lond B Biol Sci (2011) 0.90
Membrane properties of archaeal macrocyclic diether phospholipids. Chemistry (2000) 0.90
Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002. Int J Immunopharmacol (1988) 0.89
Evaluation of the Phadebact ETEC-LT test for the heat-labile enterotoxin of Escherichia coli. Zentralbl Bakteriol (1989) 0.89
Effect of Normal Immunosuppressive Protein (NIP) on tumor growth in mice. Eur J Cancer (1975) 0.88
Disputed parentage due to exchanged babies solved by HLA. Vox Sang (1980) 0.88
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol (2005) 0.88
In vitro inhibition of plaque and rosette formation by globulin. J Immunol (1972) 0.87
Self-assembly of a diferrous triple-stranded helicate with bis(2,2'-bipyridine) ligands: thermodynamic and kinetic intermediates. Inorg Chem (2000) 0.87
Inhibition of experimental tumor metastasis by selective activation of natural killer cells. Cancer Res (1982) 0.87
Role of normal immunosuppressive protein (NIP) in immunologic surveillance. Transplant Proc (1977) 0.87
Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens (1995) 0.87
Labor-associated changes in Fas ligand expression and function in human placenta. Pediatr Res (2000) 0.86
Polybrominated diphenyl ethers enhance the production of proinflammatory cytokines by the placenta. Placenta (2012) 0.86
Effect of antiarthritic drugs on the enhanced interleukin-1 (IL-1) production by macrophages from adjuvant-induced arthritic (AA) rats. Agents Actions (1987) 0.86
Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a. Biochem Pharmacol (1990) 0.86
A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4. Clin Immunol Immunopathol (1997) 0.86
Environmental and genetic factors determine the level of NK activity of nude mice and affect their suitability as models for experimental metastasis. Int J Cancer (1982) 0.86
Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis. J Rheumatol (1988) 0.86
The pharmacology of arachidonic acid-induced rat paw edema. Agents Actions (1987) 0.86
Novel diversity in IL-4-mediated responses in resting human naive B cells versus germinal center/memory B cells. J Immunol (2000) 0.85